Thermo Fisher Scientific (BSP:TMOS34) 1-Year Sharpe Ratio: 0.51 (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:TMOS34 Thermo Fisher Scientific Inc BSP:TMOS34
74 GF Score
Price R$56.89
GF Value R$61.73
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Thermo Fisher Scientific 1-Year Sharpe Ratio?

Thermo Fisher Scientific BSP:TMOS34 -0.56% 74 1-Year Sharpe Ratio is 0.51 as of Jul. 18, 2026. GuruFocus rates BSP:TMOS34 with a GF Score™ of 74/100 and a GF Value™ of R$61.73 (Fairly Valued). The stock has 5 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-18), Thermo Fisher Scientific's 1-Year Sharpe Ratio is 0.51.

Thermo Fisher Scientific  (BSP:TMOS34) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Thermo Fisher Scientific 1-Year Sharpe Ratio Related Terms

BSP:TMOS34 vs DHR, IDXX, A: 1-Year Sharpe Ratio Comparison

For the Diagnostics & Research subindustry, Thermo Fisher Scientific's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thermo Fisher Scientific 1-Year Sharpe Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Thermo Fisher Scientific's 1-Year Sharpe Ratio falls into.


BSP:TMOS34
74GF Score
Thermo Fisher Scientific Inc BSP:TMOS34
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thermo Fisher Scientific 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 0.51 mean?
Thermo Fisher Scientific (BSP:TMOS34) has a 1-Year Sharpe Ratio of 0.51 as of Jul. 18, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Thermo Fisher Scientific and its competitors.
Is Thermo Fisher Scientific's 1-Year Sharpe Ratio too high?
Thermo Fisher Scientific's current 1-Year Sharpe Ratio is 0.51. Overall, Thermo Fisher Scientific has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Thermo Fisher Scientific's 1-Year Sharpe Ratio compare to DHR and IDXX?
Thermo Fisher Scientific's 1-Year Sharpe Ratio of 0.51 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Medical Diagnostics & Research company?
A good 1-Year Sharpe Ratio depends on the Medical Diagnostics & Research industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Thermo Fisher Scientific and its competitors. Thermo Fisher Scientific's current 1-Year Sharpe Ratio is 0.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thermo Fisher Scientific stock overvalued right now?
Based on GuruFocus' analysis, Thermo Fisher Scientific (BSP:TMOS34) is currently considered Fairly Valued. The stock's GF Value™ is R$61.73, compared to a current price of R$56.89 — trading 7.8% below its estimated fair value. The current 1-Year Sharpe Ratio is 0.51. Thermo Fisher Scientific's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Thermo Fisher Scientific (BSP:TMOS34), the current 1-Year Sharpe Ratio is 0.51 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Thermo Fisher Scientific (BSP:TMOS34) Overvalued in 2026?

Based on GuruFocus' analysis, Thermo Fisher Scientific stock appears to be undervalued. The current stock price of R$56.89 is trading 7.8% below its estimated GF Value™ of R$61.73. GuruFocus considers Thermo Fisher Scientific to be Fairly Valued.

Key valuation signals for BSP:TMOS34:

  • 1-Year Sharpe Ratio: 0.51
  • GF Value™: R$61.73 vs. price of R$56.89 (7.8% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the BSP:TMOS34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Thermo Fisher Scientific Business Description

Address 168 Third Avenue, Waltham, MA, USA, 02451
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
74GF Score

Get the complete analysis for BSP:TMOS34

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$56.89
Price
R$61.73
GF Value